Anogenital cancers testing in Berbenno di Valtellina

Find health labs to test for Anogenital cancers in Berbenno di Valtellina and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Via Gaetano Donizetti, 14 24020 Castione della Presolana (BG)

22.9 km

Unverified

See Details

Pap Smear by Synlab

Largo Vittorio Veneto, 25, 24029 Vertova BG, Italia

25.4 km

Unverified

See Details

Pap Smear by Synlab

Via L. Martinelli, 2, 24026 Leffe BG, Italia

26.4 km

Unverified

See Details

Pap Smear by Synlab

Via Como, 30, 22017 Menaggio CO, Italia

26.2 km

Unverified

See Details

Pap Smear by Synlab

Corso Carlo Alberto, 78, 23900 Lecco LC, Italia

27.4 km

Unverified

See Details

Pap Smear by Synlab

Corso Carlo Alberto, 76, 23900 Lecco LC, Italia

27.4 km

Unverified

See Details

Pap Smear by Synlab

Viale Alcide De Gasperi, 2, 25047 Darfo Boario Terme BS, Italia

28.8 km

Unverified

See Details

Pap Smear by Synlab

Via 25 Aprile, 9, 23868 Valmadrera LC, Italia

28.8 km

Unverified

See Details

Pap Smear by Synlab

Via Gana, 2, 24062 Costa Volpino BG, Italia

28.9 km

Unverified

See Details

Pap Smear by Synlab

Via Donatori di Sangue, 8, 25043 Breno BS, Italia

30.6 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.